Article in Genes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
17 authors at 8 institutions in 1 country.
Andrea RemoPathology Unit, Services Department, ULSS9 "Scaligera", 37122 Verona, Italy.ORCID 0000-0002-2564-2988
Federica GrilloAnatomic Pathology, Department of Integrated Surgical and Diagnostic Sciences (DISC), University of Genoa and Ospedale Policlinico San Martino, 16132 Genoa, Italy.ORCID 0000-0001-6477-3182
Luca MastracciAnatomic Pathology, Department of Integrated Surgical and Diagnostic Sciences (DISC), University of Genoa and Ospedale Policlinico San Martino, 16132 Genoa, Italy.ORCID 0000-0003-0193-5281
Michele SimboloDepartment of Diagnostic and Public Health, Section of Pathology, University of Verona, 37135 Verona, Italy.ORCID 0000-0002-0866-4499
Matteo FassanDepartment of Medicine (DIMED), Surgical Pathology Unit, University of Padua, 35128 Padua, Italy.
Maria Paola CecchiniDepartment of Neurosciences, Biomedicine and Movement Sciences, Anatomy and Histology Section, University of Verona, 37135 Verona, Italy.ORCID 0000-0002-3583-000X
Giuseppe MiscioUnit of Pathology, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy.
Antonio SassanoUnit of Pathology, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy.
Paola ParenteUnit of Pathology, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy.ORCID 0000-0003-0591-6723
Alessandro VanoliAnatomic Pathology Unit, Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.ORCID 0000-0002-2976-7032
Giovanna Sabella1st Pathology Division, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Emanuele Damiano UrsoDepartment of Surgical, Oncological and Gastroenterological Sciences, University of Padua, 35128 Padua, Italy.ORCID 0000-0002-2789-2470
Luigi CeruloDepartment of Sciences and Technologies, University of Sannio, 82100 Benevento, Italy.
Aldo ScarpaDepartment of Diagnostic and Public Health, Section of Pathology, University of Verona, 37135 Verona, Italy.ORCID 0000-0003-1678-739X
Francesco FioricaRadiotherapy Unit, Oncology Department, ULSS9 "Scaligera", 37122 Verona, Italy.ORCID 0000-0002-9404-3655
Massimo PancioneDepartment of Sciences and Technologies, University of Sannio, 82100 Benevento, Italy.ORCID 0000-0003-1728-8816
Casa Sollievo della Sofferenza · ITUniversity of Verona · ITOspedale Policlinico San Martino · ITUniversity of Padua · ITUniversity of Sannio · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITOspedali Riuniti di Foggia · ITUniversity of Pavia · IT
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
A rhabdoid colorectal tumor (RCT) is a rare cancer with aggressive clinical behavior. Recently, it has been recognized as a distinct disease entity, characterized by genetic alterations in the
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Loss of Primary Cilia Potentiates · full record | OpenQuestion